About Conference

"27th International  Conference on  Viral Infections & Virology” on June 26-27, 2023 Athens, Greece .The  Conference  Virology 2023 is based on the

 Theme : “Combating Global Pandemics through Virology Research & Innovations.”

The primary significance of virology to all facets of the human effort is now more apparent than ever as we enter the third year of the COVID-19 outbreak. The pandemic vividly demonstrates the negative effects that viruses can have on human health and activity while also emphasizing how quickly progress in viral research can lessen the worst effects. While the COVID-19 pandemic has been on everyone's mind, we shouldn't overlook the importance of other viral infections or the utility of viruses or viral components that can be used to serve useful and important functions. We also shouldn't minimize the influence of viral systems in research across a wide range of biomedical disciplines, including molecular and cell biology, chemical biology, immunology, evolutionary biology, and structural biology.

All participants will have the opportunity to discuss research ideas with experts, keynote speakers, delegates, invited guests, authors, professors, CEOs, scientists, and eminent doctors, and to participate in a variety of discussions that will help shape future health policies and proper patient care around the world.

Scientific Sessions

Track1: General Virology

Virology  is the study of viruses and virus-like organisms, which are sub microscopic parasitic microorganisms with genetic material enclosed in a protein coat. It focuses on the structure, classification, and evolution of viruses, as well as their methods of infecting and exploiting host cells for reproduction, their interactions with host organism physiology and immunity, the diseases they cause, isolation and culture techniques, and their use in research and therapy. Microbiology has a subfield called virology.

• Molecular Biology and Immunology
• Virus–Host Interactions
• Antiviral Compounds
• RNA viruses
• DNA viruses

Track 2: DNA Viruses

A DNA virus is a virus that replicates via a DNA-dependent DNA polymerase and has DNA as its genetic material. The Baltimore categorization system divides viruses into two groups: Group I (double-stranded DNA; dsDNA) and Group II (single-stranded DNA; ssDNA). Infected cells normally extend single-stranded DNA to double-stranded DNA. Plants have a low prevalence of DNA viruses. Only lower plants, such as eukaryotic algae, are infected by dsDNA viruses, which account for 17% of all plant viruses. DNA viruses have genomes that are replicated by DNA polymerases

• Cellular Response to Infection
• Epidemiology
• Novel Model Systems

Track 3​: RNA Viruses

A virus with single-stranded and double-stranded RNA as its genetic material is known as an RNA virus. RNA viruses use virally encoded RNA-dependent RNA polymerase (RdRp) to reproduce their genomes. The RNA genome serves as a template for the creation of new RNA strands. At least three types of RNA must be created during RNA virus replication: the genome, a copy of the genome (copy genome), and mRNAs. RNA viruses have a high mutation rate and recombination is common, giving them a unique evolutionary capacity. Rapid environmental changes, such as changes in the pharmacological challenge or immunological pressure, force RNA viruses to adapt.

Track 4​:Cancer Vaccines

Vaccines are drugs that aid the body's defence against disease. They can teach the immune system to recognise and eliminate pathogens and cells. Vaccines are given to you throughout your life to protect you from common illnesses. Cancer vaccinations are also available. Vaccinations that prevent cancer and vaccines that treat cancer are available. Vaccines for cancer treatment improve the immune system's ability to detect and destroy antigens. On their surface, cancer cells frequently have chemicals termed cancer-specific antigens that healthy cells lack. When these molecules are given to a person as part of a vaccine, they behave as antigens.

• Personalized Cancer Vaccine
• Prophylactic or Preventative Vaccines
• Therapeutic or Treatment Vaccines

Track 5:Neuro Virology

Clinical neuroscience, virology, immunology, and molecular biology come together in the study of neurovirology, which is an interdisciplinary field. The study of viruses that can infect the neurological system is the field's main focus. Viruses are also used to map neuroanatomical circuits, for gene therapy, and to eradicate harmful populations of brain cells, according to the field. The field of neurovirology has only been around for 30 years. It was founded on the observation that a wide range of viruses are capable of entering nerve tissue and developing latent infections. Aging & Neurodegeneration.

• Apoptosis
• CNS Signal Transduction
• Emerging CNS Infections
• Molecular Virology

Track 6:Plant and Animal Viruses

Viruses that damage plants are known as plant viruses. Plant viruses, like all other viruses, are obligatory intracellular parasites that lack the molecular machinery to replicate in the absence of a host. Plant viruses have the potential to cause disease in higher plants. The majority of plant viruses are rod-shaped, with protein discs forming a tube around the viral genome isometric particles are another typical shape.

Animal viruses are identified by the diseases they cause, plant viruses are identified by the disease and plant species that act as hosts, and microbiological viruses are identified by the organisms they infect. Depending on the nature of their genomes, animal viruses are classified as DNA or RNA viruses.

• Host Immune System Responses
• Viral Gene Mutation
• Viral Replication

Track 7 ​:Molecular and Cellular Virology

The study of viruses at the molecular level is known as molecular virology. Viruses are small parasitic parasites that proliferate inside the cells of their hosts. Viruses have more biological diversity than the rest of the bacterial, plant, and animal kingdoms combined because they can successfully infect and parasitize a wide range of life forms, from microbes to plants and animals. Understanding how viruses interact with their hosts, replicate inside them, and because diseases require a deeper understanding of their diversity.

• Gene Expression
• Genome Replication
• Host-Pathogen Interactions
• Medical Implications and Consequences
• Molecular Mechanisms

Track 8:Advances in Virology Research

The study of the biology of viruses and viral diseases, including their distribution, biochemistry, physiology, molecular biology, ecology, evolution, and clinical aspects, is referred to as virology. Virology is a branch of study that focuses on traditional virology fields like classification, structure infection, and therapy, as well as advanced scientific domains. Virology is frequently lumped in with microbiology and pathology. Virology's early years were reliant on breakthroughs in the chemical and physical sciences; yet, viruses quickly evolved into tools for examining basic biochemical processes in cells.

• Viral Structure
• Function and Genetics
• Virus-Host Interactions
• Viral Disease Outbreaks
• Antiviral
• Therapeutics
• Viral Vectors

Track 9​:Coronavirus Disease (COVID-19)

Coronavirus disease (COVID-19) is a newly found coronavirus that causes an infectious disease. Coronaviruses are a type of virus that can infect humans and cause respiratory disease. The multiple crown-like spikes on the surface of the virus give it the name "corona." Coronaviruses that cause sickness in humans include SARS, Middle East respiratory syndrome (MERS), and the common cold. The majority of patients infected with the COVID-19 virus will have mild to moderate respiratory symptoms and will recover without needing any specific therapy. \

Track 10:Viral Sequencing

Viruses are the most common biological entities on the planet, and they have a huge impact on living beings by producing diseases and influencing their immune systems. Viruses are sequenced in less than 0.01 percent of cases, despite their widespread presence and significance. In terms of etiopathogenesis and the development of innovative therapies, the research of viral infectious diseases is experiencing significant developments at the moment. Virus genome sequencing is an important and fast evolving technology for diagnosing COVID-19 and understanding how the novel coronavirus spreads and is controlled.

Track 11​:Viral Respiratory Diseases

Respiratory viruses are the most common cause of sickness in humans, with considerable morbidity and mortality rates around the world. Community-based investigations undertaken over the last five decades or so demonstrate that common respiratory agents from several virus families are the primary etiological agents of acute respiratory infections (ARIs). The severity of viral respiratory illness varies, but it is more common in elderly people and new-borns. Despite the fact that respiratory viruses cause a wide variety of diseases, there are now just a few preventive or therapeutic strategies available. Recent discoveries in respiratory virus molecular and cell biology, on the other hand, should lead to the development of helpful therapies.

Track 12​:Virus Morphology, Genetics, Replication

Viruses are distinct from all other living species, whether eukaryotes or prokaryotes, in three ways: (1) the environment in which they grow and multiply, (2) the nature of their genome, and (3) the manner of their replication. To begin with, they can only function and multiply inside another live organism, which could be a prokaryotic or eukaryotic cell depending on the virus. Viruses are obligate parasites that are a cellular and biologically inert outside of the host cell. Viruses are a diverse group of microorganisms with varying sizes, morphologies, and chemical compositions.

Track 13​:Clinical Cases and Trials

A clinical case definition, also known as a clinical definition or simply a case definition, is a list of clinical criteria used by public health professionals to determine whether a person's illness should be included as a case in an outbreak investigation—that is, whether a person should be considered directly affected by an outbreak. In the absence of an outbreak, case definitions are used in public health monitoring to classify the disorders that exist in a community. A case definition establishes boundaries for a case by limiting time, person, place, and shared definition of the phenomenon under investigation. All cases of a disease documented from a specific time period may be included in the time criteria.

Track 14​:HIV and STDs

The term STD refers to a sexually transmitted disease. Sexually transmitted infections (STIs) are another term for STDs. STDs are infections that are transmitted from one person to another by sexual activity, such as anal, vaginal, or oral sex. Bacteria, parasites, and viruses are all responsible for STDs.

HIV (human immunodeficiency virus) is a virus that affects cells in the body that help it fight infections, making a person more susceptible to other infections and diseases.

Track 15: Emerging Infectious Diseases

Infections  that have recently appeared in a population or whose incidence or geographic range is fast expanding or threaten to increase in the near future are known as emerging infectious diseases. In a 2007 report, the World Health Organization cautioned that infectious illnesses are arising at an unprecedented rate. About 40 infectious diseases have been found since the 1970s, including SARS, MERS, Ebola, chikungunya, avian flu, swine flu, Zika, and, most recently, COVID-19, which is caused by the SARS-CoV-2 coronavirus. People are travelling much more frequently and over much longer distances than in the past, living in more densely populated places, and coming into closer contact with wild animals, so the potential for new infectious diseases to spread quickly and trigger worldwide epidemics is a serious concern

Benefits of Participation

• The advantages of the Speaker  and abstract pages are created in Google on your profile under your name would get worldwide visibility.
• Our comprehensive Online Advertising attracts 30000+ users and 50000+ views to our Library of Abstracts, which takes researchers and speakers to our webinar.
• Meet with hundreds of like-minded experts who are pioneers in Virology and share ideas.
• All participants in the  Conference would have a different reason to participate with eminent speakers and renowned keynote speakers in one-to-one meetings.
• A rare opportunity to listen what the world's experts are learning about from the world's most influential researchers in the area of Virology  at our Keynote sessions.
• Virology intensive webinar schedule, you will acquire experience and expertise in strategic gift preparation that is worth its weight golf, forming an impressive array of recognised professionals.
• Best Poster Award nominations.
• Award for Outstanding Young Researcher.
• Group Registration Advantages.

Benefits of Participation for Speaker

• Worldwide appreciation of the profile of Researchers.
• Obtain credits for professional growth.
• Explore the latest of cutting edge analysis.
• Make long-term bonds at Social And Networking activities.
• An ability to advertise one page in the distribution of abstract books and flyers that ultimately gets 1 million views and adds great value to your research profile.
• Learn a transition beyond your area of interest to learn more about new subjects and studies away from your  core subject of Virology .
• We have distinctive networking, learning and enjoyable integration into a single package.

Benefits of Participation for Delegate

• Professional Development-Improve understanding and  Knowledge.
• Attendance at webinars supports rejuvenates and energises delegates.
• Your involvement in our webinar will help with a new methodology and ideology that can be used to broaden the outcomes of Businesses or industries.
• Opportunities for Virology researchers and experts in the same field to meet and exchange new ideas through an Online Webinar.

Benefit of Participation for Sponsor

• Exposure to the international environment would increase the possibility of  New Companies.
• Opportunity to demonstrate your company's Latest Technologies, new products, or service your business to a wide range of international participants.
• Increase business by our webinar participants through lead generation.
• It takes a lot of time, effort and drive to create a successful company, so it's always nice to have a network of Colleagues and associates to draw energy from individuals who share a common drive and objective.
• Webinars in neurology provide opportunities for more attention and contemplation that could help you move your company to the next stage.
• Benchmarking main Organization plans and moving it forward.
• Get feedback from trustworthy people at our webinar to your company questions and challenges.
• On our webinar banner, website and other proceedings, branding and Marketing content, the Advertising Logo of your company.

Benefit of Association for Collaborators

• Nobody has these massive visitors to Virology  in the world; this is the best forum to highlight society.
• Creating long-lasting peer relationships.
• In our Conference banner, website and other proceedings, branding and marketing material, promotional content and your Organization logo will increase your number of subscribers/members by 40%.
• The exposure of our event to your Company listing in the Global Business forum will have a great effect on your association.
• Your representatives can network to update their knowledge and understanding of your organisation and services with key webinar Delegates.
• Virology advertising materials such as posters, Brochures, pamphlets, services that will be circulated to hospitals, universities, society and researchers will be integrated with information.

Market Analysis

The global virology specimen collection market size is projected to be worth ~USD 8,974 million by 2030, registering a CAGR of ~5.3% during the forecast period (2021 - 2030)

Specimen collection is the process of obtaining substances for laboratory analysis or near-patient testing. The sample collection kit includes the vitals and reagents used in collecting samples and shipping them to the laboratory, where the testing services will be performed. There is a rise in the demand for virology specimen collection kits due to the increasing incidence of various viral diseases, COVID-19 outbreak globally, and approval of new and advanced detection tests by authorities. In May 2020, Everlywell, Inc. received an emergency use authorization (EUA) from the Food and Drug Administration (FDA) for the COVID-19 test sample collection kit. The product is a standalone, at-home nasal swab sample collection kit with a saline-filled tube that can be sent to specified labs for subsequent COVID-19 diagnostic testing. This, in turn, has positively impacted the virology specimen collection market.

Global Virology Testing Market, By Procedure (Cell Culture Method, Specific Antibodies Detection, Antigen Detection, Virus Nucleic Acid Detection, Gene Sequencing, Hemagglutination Assays), Diagnosis Test (Hepatitis B, Hepatitis C, HIV, Human Papillomavirus (HPV), Other Tests), Method (Immunoprophylaxis, Active Prophylaxis (Vaccines), Passive Prophylaxis, Antiviral Chemotherapy, Interferon's (Cytokines)), Application (Skin and Soft Tissue Infections, Respiratory Tract Infections, GI Tract Infections, Urinary Tract Infection, Eye Infections, Sexually Transmitted Diseases, Perinatal Infections), End User (Hospitals, Clinics, Laboratories, Diagnostic Centers, Blood Banks, Pharmacies) – Industry Trends and Forecast to 2029.